Please don''t sell the Lorenzini shares & it will raise up to 40-42 within couple of months as market is getting recovery. And also company has very good flow from upcoming budget. So definitely it will give very good return.
I started using this site since 2014, initially I gathered a lot of information on IPOs and SMEs...It gives me shock to know that many boarders for Lorenzini posting messages...It looks like they all registered with this site last week I presume....or hired by them to get subscription ???
We should be very careful with this Lead Manager and Market Maker like Guinness Securities...they will wash of their hands on 3rd day or 4th day...this was happened in ANG lifescience ...1st day UC, 2nd UC and 3rd UC and Lower circuit there is no movement of this ANG after that we burned our fingers for 2 lots Rs 1 lac losss.....
your mail may be right. But ANG lifesciences issued at 80 and listed and closed at 96 on first day and you could have sold it. now it is around issue price of 78 or so. so you could not have made lost of 1 lakh in 2 lots. max
Would like to to give reply to the Reply from SSKI - I was not primary allotte in ANG Lifescience - 1st day UC @ Rs 96 with vol of 1,96,000 and 2nd UC at Rs 115.20 with volume of 7,48,000 We bot at 3 lots ANG Life at UC at Rs 115.20 and on the same day is 20% lower circuit...reached to issue price - Dear SSKI count your loss it will be around Rs 1,62,000 +
SME IPO is mainly for HNI client only who can hold long term. For retail investors it''s just for listing gains.Retail investors should not buy in secondary market. If. U get it IPO selkl it on listing and if you have more than one lot keep the other with some stop-loss. The mistake of High Flyer is buying in secondary market.never make that mistake. Just apply IPO and book profit on listing is the SME mantra.
The Company seems to be diluting almost 44%-45% which is very high on the first place and that too at the face value. The Lead Manager i.e. Fedex is a new player with not much experience and its first IPO Shree Ganesh Remedies had opened at 17% discount. Considering the track record of Company and LM...A BIG AVOID!!!
Shree Ganesh Remedies Ltd. is a fundamentally sound company and in long run, it may give good return in comparison to other contemporary SME Pharma companies. For a value investor, it is a buy at current price and it was a great accumulate at listing day discount price.
I think the Market Maker is to provide liquidity in the counter only. It is upto the public to sell at lower or higher levels hence driving the prices. Fundamentals of the company is important and need to be analysed to see if there can be a growth story and what has been the performance and business model of the company.
If Merchant Banking assignment already gone to Fedex why they have not filed DRHP again with their name? The DRHP filed here states Guiness. Hence it can be mis-leading to us investors.